Wei Yan

Dr. Wei Yan


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 June 2022 in Molecular Psychiatry
Verified
Journal Article
Closed access
PDF file
NZNa Zeng
Na Zeng
YZYi-Miao Zhao
Yi-Miao Zhao
WYWei Yan
Wei Yan
CLChao Li
Chao Li
QLQing-Dong Lu
Qing-Dong Lu
LLLin Lu
Lin Lu

7 May 2021 in Molecular Psychiatry
Verified
Journal Article
Closed access
PDF file
ZWZhong Wang
Zhong Wang
WCWen-Hao Chen
Wen-Hao Chen
SLSu-Xia Li
Su-Xia Li
ZHZhong-Ming He
Zhong-Ming He
WZWei-Li Zhu
Wei-Li Zhu
YHYing Han
Ying Han

6 June 2022 in Molecular Psychiatry
Verified
Journal Article
Closed access
PDF file
KYKai Yuan
Kai Yuan
YZYong-Bo Zheng
Yong-Bo Zheng
YWYi-Jie Wang
Yi-Jie Wang
YSYan-Kun Sun
Yan-Kun Sun
YGYi-Miao Gong
Yi-Miao Gong
LLLin Lu
Lin Lu

27 September 2021 in Molecular Psychiatry
Verified
Journal Article
Closed access
PDF file
KYKai Yuan
Kai Yuan
XHXiao-Lin Huang
Xiao-Lin Huang
WYWei Yan
Wei Yan
YZYu-Xin Zhang
Yu-Xin Zhang
YGYi-Miao Gong
Yi-Miao Gong
LLLin Lu
Lin Lu

25 July 2023 in Molecular Psychiatry
Verified
Journal Article
Closed access
PDF file
SSSizhen Su
Sizhen Su
YZYimiao Zhao
Yimiao Zhao
NZNa Zeng
Na Zeng
XLXiaoxing Liu
Xiaoxing Liu
YZYongbo Zheng
Yongbo Zheng
LLLin Lu
Lin Lu

23 January 2023 in Molecular Psychiatry
Verified
Journal Article
Open access
PDF file
YZYimiao Zhao
Yimiao Zhao
LSLe Shi
Le Shi
ZJZhendong Jiang
Zhendong Jiang
NZNa Zeng
Na Zeng
HMHuan Mei
Huan Mei
LLLin Lu
Lin Lu
Long-term sequelae clustering phenotypes are important for precise health care management in COVID-19 survivors. We reported findings for 1000 survivors 20 months after diagnosis of COVID-19 in a community-based cohort in China. Sequelae symptoms were collected from a validated questionnaire covering 27 symptoms involved in five organ systems including self-reported physical condition, dyspnea, cognitive function and mental health. The generalized symptoms were reported with the highest rate (60.7%), followed by the mental (48.3%), cardiopulmonary (39.8%), neurological (37.1%; cognitive impairment, 15.6%), and digestive symptoms (19.1%). Four clusters were identified by latent class analysis: 44.9% no or mild group (cluster 1), 29.2% moderate group with mainly physical impairment (cluster 2), 9.6% moderate group with mainly cognitive and mental health impairment (cluster 3), and 16.3% severe group (cluster 4). Physical comorbidities or history of mental disorders, longer hospitalization periods and severe acute illness predicted severe group. For moderate group, adults less than 60 years, with physical comorbidities and severe acute illness were more likely to have physical symptoms, while adult women with longer hospitalization stays had increased risk of cognitive and mental health impairment. Overall, among more than half of community COVID-19 survivors who presented moderate or severe sequelae 20 months after recovery, three-tenth had physical vulnerability that may require physical therapy aiming to improve functioning, one-tenth mental or cognitive vulnerable cases need psychotherapy and cognitive rehabilitation, and one-sixth severe group needs multidisciplinary clinical management. The remaining half is free to clinical intervention. Our findings introduced an important framework to map numerous symptoms to precise classification of the clinical sequelae phenotype and provide information to guide future stratified recovery interventions.